Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
$19.7M
Mar 2020
$9.8M
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
$13.8M
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
+138.4%
Mar 2020
+29.7%
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
+30.1%
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
$2.7M
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Single quarter
Debt to equity
0.02x
long-term 2023-12-31 plus current 2025-12-31; equity 2025-12-31
Debt to equity CHR
FY Dec 2025
0.02x
FY Dec 2024
0.05x
FY Dec 2023
0.02x
FY Dec 2022
0.00x
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
2.84x
TTM operating cash flow over long-term 2023-12-31 plus current 2025-12-31
Cash flow to debt CHR
FY Dec 2025
2.84x
FY Dec 2024
1.85x
FY Dec 2023
4.24x
FY Dec 2022
4,216.20x
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
+142.6%
Jun 2019
+278.8%
Mar 2019
+39.7%
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
+2.8%
Jun 2019
+2.7%
Mar 2019
+2.3%
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
+1.2%
Jun 2019
+1.5%
Mar 2019
+1.7%
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no close on file at or before the as-of date
Enterprise value CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no close on file at or before the as-of date
FCF yield CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing CHR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2020
n/a
Mar 2020
n/a
Dec 2019
n/a
Sep 2019
n/a
Jun 2019
n/a
Mar 2019
n/a
Dec 2018
n/a
Sep 2018
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CHR ranks highest on financial health (81st percentile) and risk and compliance (56th), and lowest on growth (32nd), among Software & IT peers.
Financial health
81
Inputs
Debt to equity0.02x · 73 pct, sector of 288
Cash flow to debt2.84x · 89 pct, sector of 241
Growth
32
Inputs
Revenue growth, YoY+1.1% · 32 pct, sector of 480
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
56
Inputs
Short interest, % of float+4.0% · 56 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Insider conviction, Institutional and government, US patents
Profitability needs 2 of 4 inputs, 0 present: the filed year and its quarters do not reconcile, so the trailing figure is withheld
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CHR filings, in plain words
Read the full summary
1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 100.0% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.